Skip to main content
. 2020 Aug 18;9(8):768. doi: 10.3390/antiox9080768

Figure 7.

Figure 7

Effects of NIC, 6HLN and COT (0.3 mg/kg, b.w., i.p.) administration in Aβ25-35-treated rats on (A) AChE-specific activity and oxidative status, represented by (B) SOD, (C) CAT and (D) GPX-specific activities along with the content of (E) GSH, (F) carbonylated proteins and (F) MDA in the hippocampus. Values are expressed as means ± S.E.M. (n = 6 animals per group). ANOVA analysis revealed overall significant differences between groups in (A) F(4,10) = 48.92, p < 0.0001, (B) F(4,10) = 100.7, p < 0.0001, (C) F(4.10) = 30.49, p < 0.0001, (D) F(4,10) = 18.15, p < 0.0001, (E) F(4,10) = 30.06, p < 0.0001, (F) F(4,10) = 32.55, p < 0.0001 and (G) F(4,10) = 26.87, p < 0.0001. For Tukey post hoc analyses – (A)*** Control vs. Aβ25-35, NIC vs. Aβ25-35, 6HLN vs. Aβ25-35, COT vs. Aβ25-35, Aβ25-35 vs. 6HLN + Aβ25-35, Aβ25-35 vs. COT + Aβ25-35: p < 0.0001, ** Aβ25-35 vs. NIC + Aβ25-35, NIC + Aβ25-35 vs. 6HLN + Aβ25-35, 6HLN + Aβ25-35 vs. COT + Aβ25-35: p < 0.001, * Control vs. NIC + Aβ25-35 vs: p < 0.01; (B) *** Control vs. Aβ25-35, Control vs. COT + Aβ25-35, NIC vs. Aβ25-35, 6HLN vs. Aβ25-35, COT vs. Aβ25-35, Aβ25-35 vs. NIC + Aβ25-35, Aβ25-35 vs. 6HLN + Aβ25-35: p < 0.0001, ** Aβ25-35 vs. COT + Aβ25-35, 6HLN + Aβ25-35 vs. COT + Aβ25-35: p < 0.001, *NIC + Aβ25-35 vs. COT + Aβ25-35: p < 0.01; (C) *Control vs. Aβ25-35: p < 0.001, *** NIC vs. Aβ25-35, 6HLN vs. Aβ25-35, COT vs. Aβ25-35, Aβ25-35 vs. NIC + Aβ25-35, Aβ25-35 vs. 6HLN + Aβ25-35: p < 0.0001, * Aβ25-35 vs. COT + Aβ25-35, 6HLN + Aβ25-35 vs. COT + Aβ25-35: p < 0.01; (D) ** Control vs. Aβ25-35, Aβ25-35 vs. 6HLN + Aβ25-35: p < 0.001, *NIC vs. Aβ25-35, 6HLN vs. Aβ25-35, COT vs. Aβ25-35, Aβ25-35 vs. NIC + Aβ25-35, Aβ25-35 vs. COT + Aβ25-35: p < 0.01; (E) *Control vs. NIC + Aβ25-35, NIC + Aβ25-35 vs. COT + Aβ25-35: p < 0.01, ** Control vs. Aβ25-35, NIC vs. Aβ25-35, 6HLN vs. Aβ25-35, COT vs. Aβ25-35, Aβ25-35 vs. COT + Aβ25-35, NIC + Aβ25-35 vs. 6HLN + Aβ25-35: p < 0.001, *** Aβ25-35 vs. 6HLN + Aβ25-35: p < 0.0001; (F) *** Control vs. Aβ25-35, NIC vs. Aβ25-35, 6HLN vs. Aβ25-35, COT vs. Aβ25-35, Aβ25-35 vs. NIC + Aβ25-35, Aβ25-35 vs. 6HLN + Aβ25-35, Aβ25-35 vs. COT + Aβ25-35: p < 0.0001; (G) *** Control vs. Aβ25-35, NIC vs. Aβ25-35, 6HLN vs. Aβ25-35, COT vs. Aβ25-35, Aβ25-35 vs. NIC + Aβ25-35, Aβ25-35 vs. 6HLN + Aβ25-35, Aβ25-35 vs. COT + Aβ25-35: p < 0.0001.